AMW

Leuprorelin implant

For the treatment of metastatic and locally advanced prostate cancer, endometriosis and advanced breast cancer.

Leuprorelin is just likegoserelinan analogue of the hormone gonadotropin. Inhibiting the release of sex hormones results in the same areas of application, prostate cancer, breast cancer and endometriosis.

AMW GmbH has independently developed leuprorelin implants with a dosage of 11.25 mg (three-month implant). Other dosages are also in development.